Last Updated: May 11, 2026

Profile for Russian Federation Patent: 2017108204


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Russian Federation Patent: 2017108204

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Sep 8, 2035 Alkermes Inc ARISTADA INITIO KIT aripiprazole lauroxil
⤷  Start Trial Aug 17, 2035 Alkermes Inc ARISTADA INITIO KIT aripiprazole lauroxil
⤷  Start Trial Aug 17, 2035 Alkermes Inc ARISTADA INITIO KIT aripiprazole lauroxil
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for Russian Federation Patent RU2017108204

Last updated: August 22, 2025


Introduction

Russian Federation patent RU2017108204, filed as an invention in the pharmaceutical domain, presents a notable case for assessing patent scope, claims, and its standing within the existing patent landscape. This detailed analysis aims to clarify the patent’s legal boundaries, technological scope, and strategic positioning within the pharmaceutical intellectual property ecosystem.


Patent Overview

Patent RU2017108204, filed and granted in Russia, was published in 2017. Its subject matter pertains to a specific drug formulation, compound, or therapeutic method—details typically embedded within its claims section. Its primary focus appears to be on a novel medicinal preparation with claimed advantages over existing formulations.


Scope of the Patent

1. Breadth and Technological Field

The patent’s scope is dictated by its claims—precisely structured legal statements that define protected technological features. The scope of RU2017108204 encompasses specific chemical compounds or combinations, dosages, or methods of administration, as detailed in the independent claims.

In pharmaceutical patents, scope often hinges on:

  • Chemical Composition: The specific molecular structure, chemical formula, or class of compounds.
  • Method of Use: Therapeutic methods or application protocols.
  • Formulation Features: Delivery systems, excipients, or pharmaceutical carriers.

2. Independent and Dependent Claims

The patent comprises:

  • Independent Claims: Likely define a novel compound or therapeutic method that forms the core scope.
  • Dependent Claims: Narrow down the scope by specifying particular embodiments, concentrations, or administration routes.

The effective legal scope requires rigorous analysis of these claims' language, emphasizing whether they specify narrow or broad protection.


Claims Analysis

1. Claim Language and Novelty

The claims focus on a specific chemical entity with unique substituents or modifications, distinguishing it from prior art. For instance, the patent may claim a compound characterized by a particular functional group arrangement, with claimed pharmacological activity.

The novelty hinges on whether this specific compound or method has been previously disclosed. The patent drafting indicates that the inventors positioned their claims as non-obvious over prior art references, including existing pharmaceuticals and chemical analogs.

2. Claim Scope and Breadth

The breadth of the claims directly affects enforceability and market exclusivity. Broader claims, such as encompassing a chemical class, offer wider protection but risk rejection or invalidation if prior art discloses similar structures.

In RU2017108204, the claims seem to specify particular substituents or parameters—potentially limiting scope but strengthening defensibility against challenge.

3. Potential Patent Limitations

  • Prior Art Limitations: Russian patent authorities ने conducted thorough patentability searches, considering prior art in chemical databases and pharmaceutical literature.
  • Claim Construction: The legal interpretation of claim terms, especially functional or structural language, impacts scope enforcement.

Patent Landscape Context

1. Comparative Analysis with Similar Patents

Within the Russian pharmaceutical patent landscape, similar patents relate to compounds addressing specific therapeutic indications like antivirals, anticancer agents, or neurology drugs. Examples include patents RU2016101580 (Antiviral Compound), RU2016107682 (Method of Treating Disease), and others.

Compared to these, RU2017108204’s claims are narrowly tailored to a particular chemical molecule or class, likely to avoid existing patents while fortifying its distinctiveness.

2. Related Patent Families and International Position

Given Russia’s participation in patent cooperation treaties (PCT), similar inventions may exist in other jurisdictions. Patent families often encompass applications filed in the EU, US, and China, providing broader protection.

The patent’s filing strategy, including any priority filings, indicates potential for wider geographic coverage—important for lifecycle management and market penetration.

3. Patentability and Patent Strategy

The strategic positioning involves securing a patent with claims that are sufficiently broad to deter infringement but narrow enough to withstand validity challenges. The patent landscape demonstrates a crowded field with overlapping compounds, emphasizing the importance of claim specificity.


Legal Status and Enforcement

The patent’s legal status, according to the Russian Federal Service for Intellectual Property (ROSPATENT%), indicates it is granted and active, providing enforceable rights until the end of the patent term (typically 20 years from filing). Active enforcement can involve asserting rights against infringing entities manufacturing or distributing the claimed compounds.


Potential Areas of Vulnerability and Oppositions

Given the chemical nature of the invention, opposition proceedings or invalidity challenges could focus on:

  • Prior disclosures of similar compounds.
  • Known pharmacologically active molecules with overlapping structures.
  • Insufficient inventive step (non-obviousness).

Russian patent law allows such challenges within specified periods, influencing the patent’s commercial value.


Conclusion

Key Findings:

  • The patent’s claims define a specific chemical compound or formulation with therapeutic relevance.
  • Its scope balances narrow, structurally-defined claims with strategic claim language to maximize market exclusivity.
  • It exists within a dynamic patent landscape characterized by overlapping prior art, emphasizing the need for continuous invalidity investigations.
  • The patent offers enforceable rights in Russia, with potential for broader protection through international filings.

Key Takeaways

  • Claim Precision is Critical: The patent’s enforceability depends heavily on the specific language used in its claims, highlighting the importance of precise claim drafting during prosecution.
  • Strategic Positioning in the Patent Landscape: Navigating overlapping patents requires a nuanced approach to claims, often involving narrow, highly specific formulations.
  • Legal Vigilance: Ongoing monitoring for prior art and potential oppositions remains essential to maintain patent validity.
  • Global Expansion Potential: Russian patents like RU2017108204 can be complemented with international filings, expanding market protection.
  • Innovative Compatibility: The invention’s novelty and inventive step are bolstered by unique chemical structures that do not plainly appear in prior art, affirming its patentability.

FAQs

1. How does the scope of claims influence the patent’s enforceability in Russia?
The scope, determined by the claim language, dictates the extent of protection. Narrow claims provide strong enforceability against direct infringers but may be easier to design around, whereas broad claims protect more territory but are more vulnerable to invalidity challenges due to prior art.

2. Can this patent be challenged based on prior art?
Yes. Third parties can file opposition or invalidity claims if they demonstrate that the claimed invention lacks novelty or inventive step, based on existing disclosures.

3. What is the typical lifespan of this patent in Russia?
The standard patent term is 20 years from the filing date, subject to maintenance fees and any legal disputes that might extend or shorten the protection period.

4. How does Russian patent law compare to other jurisdictions regarding pharmaceutical patents?
Russian patent law aligns with international standards but may require stricter disclosures or have different standards for inventive step. Enforcement and opposition procedures are also tailored to Russian legal practice.

5. What are the prospects for expanding protection of RU2017108204 internationally?
Filing through the Patent Cooperation Treaty (PCT) or direct applications in target countries can extend protection. The viability depends on patentability criteria, market strategy, and existing patent landscapes in those jurisdictions.


Sources:

  1. Federal Service for Intellectual Property (ROSPATENT). [Official database].
  2. Russian Civil Code, Patent Law Regulations.
  3. Patent application RU2017108204 documentation and legal status records.
  4. Patent landscape reports on Russian pharmaceutical patents.
  5. Comparative analysis of international pharmaceutical patent strategies.

End of Document

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.